Oregon Department of Corrections
Approved Formulary
Search by name
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
February P&T meeting minutes have been posted.
Oregon Department of Corrections
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Search results for:
lithium
lithium
Earned In-Cell
If AIC demonstrates adherence to proper regimen for 60 or more days
Brand names:
ESKALITH, Lithium Carbonate, Lithium Citrate, LITHOBID, LITHOCAPS
Form
Strength
CAPSULE, ORAL
150 mg; 300 mg
SYRUP, ORAL
300 mg/5 mL
TABLET, EXTENDED RELEASE, ORAL
300 mg; 450 mg
Additional Information:
NOVEMBER 2013 P&T MINUTES
Last updated:
Aug. 20, 2021
Black Box Warning:
Monitoring recommendations
UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier
NOVEMBER 2013 P&T MINUTES